Doximity’s DOCS shares have lost approximately 4.4% despite the company reporting solid fourth-quarter fiscal 2025 results ...

Healthcare professional network Doximity (NYSE:DOCS) will be reporting results tomorrow after the bell. Here’s what to look ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $61.42, a high estimate of ...

Doximity DOCS ended the fiscal 2025 with robust growth in its top line. The performance is also likely to continue in fiscal 2026 as demand for telehealth and related services continues to rise.

Leading digital healthcare platform Doximity rocketed past analysts' expectations, but offered up disappointing guidance. Trading at a premium valuation, the company sold off as the market fretted ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Doximity beats analyst estimates on the top and bottom lines in the fourth quarter. Doximity issues guidance for the first quarter and full-year 2026 below analyst expectations. Ready to turn the ...

Digital medical platform leader Doximity reported better-than-expected results on the top and bottom lines. Free cash flow grew by more than 50% year over year, and margins are stellar.

Over the past month, Doximity’s DOCS shares have lost approximately 4.4% despite the company reporting solid fourth-quarter fiscal 2025 results with $138.3 million in revenues and a 50% adjusted ...

Shares of Doximity (NYSE: DOCS) rocketed 35% higher as of 1:45 p.m. ET Friday, according to data provided by S&P Global Market Intelligence, after the company reported fiscal second-quarter ...